Brain angiotensin peptides regulate sympathetic tone and blood pressure

Journal of Hypertension

Volumn 28, Issue 8, 2010, Pages 1599-1610

  Dupont, Alain G ^a   Brouwers, Sofie ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

blood pressure; brain renin angiotensin system; sympathetic tone

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR ANTAGONIST; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PRESYNAPTIC RECEPTOR; VASOPRESSIN;

ANTERIOR HYPOTHALAMUS; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE REGULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; HUMAN; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MEAN ARTERIAL PRESSURE; MICROINJECTION; MOLECULAR INTERACTION; NONHUMAN; PRESSORECEPTOR REFLEX; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE;

EID: 77954956655     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833af3b2     Document Type: Review

References (169)

1. Dampney RA. Medullary pathways regulating sympathetic outflow: the need for more lateral thinking. Am J Physiol Regul Integr Comp Physiol 2004; 286:R446-R448.
2. Dampney RA, Horiuchi J, Killinger S, Sheriff MJ, Tan PS, McDowall LM. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin Exp Pharmacol Physiol 2005; 32:419-425.
3. Guild SJ, Barrett CJ, Malpass SC. Long-term recording of sympathetic nerve activity: the new frontier in understanding the development of hypertension. Clin Exp Pharmacol Physiol 2005; 32:433-439.
4. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006; 7:335-346.
5. Katholi RE, Rocha-Singh KJ. The role of renal sympathetic nerves in hypertension: has percutaneous renal denervation refocused attention to their clinical significance? Prog Cardiovasc Dis 2009; 52:243-248.
6. Schlaich MP, Whitbourn R, Sobotka PA, Bartus K, Kapelak B, Walton A, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373:1275-1281.
7. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361:932-934.
8. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension. Novel implications for an old concept. Hypertension 2009; 54:1195-1201.
9. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 2010; 298:R245-R253.
10. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74:323-364.
11. Dampney RA, Horiuchi J, Tagawa T, Fontes MA, Potts PD, Polson JW. Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone. Acta Physiol Scand 2003; 177:209-218.
12. Kantzides A, Badoer E. nNOS-containing neurons in the hypothalamus and medulla project to the RVLM. Brain Res 2005; 1037:25-34.
13. Sun MK, Hacket JT, Guyenet PG. Sympathoexcitatory neurons of rostral ventrolateral medulla exhibit pacemaker properties in the presence of a glutamate-receptor antagonist. Brain Res 1988; 438:23-40.
14. Pan HL. Brain angiotensin II and synaptic transmission. Neuroscientist 2004; 10:422-431.
15. Ross CA, Ruggiero DA, Park DH, Joh TH, Sved AF, Fernandez-Pardal J, et al. Tonic vasomotor control by the rostral ventrolateral medulla: effect of electrical or chemical stimulation of the area containing C1 adrenaline neurons on arterial pressure, heart rate, and plasma catecholamines and vasopressin. J Neurosci 1984; 4:474-494.
16. Guyenet PG, Stornetta RL, Weston MC, McQuiston T, Simmons JR. Detection of amino acid and peptide transmitters in physiologically identified brainstem cardiorespiratory neurons. Auton Neurosci 2004; 114:1-10.
17. Schreihofer AM, Guyenet PG. The baroreflex and beyond: control of sympathetic vasomotor tone by GABAergic neurons in the ventrolateral medulla. Clin Exp Pharmacol Physiol 2002; 29:514-521.
18. Pointer MA. Is central nitric oxide essential in hypertension? J Hypertens 2005; 23:1637-1638.
19. Esler M. The sympathetic system and hypertension. Am J Hypertens 2000; 13:99S-105S.
20. Zucker IH, Patel KP, Schultz HD, Li YF, Wang W, Pliquett RU. Exercise training and sympathetic regulation in experimental heart failure. Exerc Sport Sci Rev 2004; 32:107-111.
21. Sanderford MG, Bishop VS. Central mechanisms of acute ANG II modulation of arterial baroreflex control of renal sympathetic nerve activity. Am J Physiol Heart Circ Physiol 2002; 282:H1592-H1602.
22. 1 receptors in the nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 2007; 293:R2267-R2278.
23. Fisher-Ferraro C, Nahmod VE, Goldstein DJ, Finkielman S. Angiotensin and renin in the rat and dog brain. J Exp Med 1971; 133:353-361.
24. Ganten D, Speck G. The brain renin-angiotensin system: a model for the synthesis of peptides in the brain. Biochem Pharmacol 1978; 27:2379-2389.
25. Ganong WF. The brain renin-angiotensin system. Ann Rev Physiol 1984; 46:17-31.
26. 1 receptors. Am J Hypertens 2000; 13:31S-38S.
27. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, et al. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 2003; 35:901-918.
28. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109:1417-1427.
29. Shan Z, Cuadra AE, Sumners C, Raizada MK. Characterization of a functional (pro)renin receptor in rat brain neurons. Exp Physiol 2008; 93:701-708.
30. Contrepas A, Walker J, Koulakoff A, Franek KJ, Qadri F, Giaume C, et al. A role of the (pro)renin receptor in neuronal cell differentiation. Am J Physiol Regul Integr Comp Physiol 2009; 297:250-257.
31. Morimoto S, Cassell MD, Beltz TG, Johnson AK, Davisson RL, Sigmund CD. Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. Circ Res 2001; 89:365-372.
32. 1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Res 1994; 665:245-252.
33. Hirooka Y, Potts PD, Dampney RA. Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of rabbits. Brain Res 1997; 772:107-114.
34. Philips MI, Summers C. Angiotensin II in central nervous system physiology. Regul Pept 1998; 78:1-11.
35. Averill DB, Diz DI. Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res Bull 2000; 51:119-128.
36. Dampney RA, Fontes MA, HirookaY, HoriuchiJ,Potts PD, Tagawa T.Role of angiotensin II receptors in the regulation of vasomotor neurons in the ventrolateral medulla. Clin Exp Pharmacol Physiol 2002; 29:467-472.
37. Mendelsohn FA. Localization and properties of angiotensin receptors. J Hypertens 1985; 3:307-331.
38. Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY, Mendelsohn FA. Angiotensin receptors in the nervous system. Brain Res Bull 1998; 47:17-28.
39. 1 receptors mediate excitatory inputs to RVLM pressor neurons from hypothalamus. Hypertension 1999; 34:1301-1307.
40. Yang R, Smolders I, De Bundel D, Fouyn R, Hallberg M, Demaegdt H, et al. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat. J Hypertens 2008; 26:998-1007.
41. Mendelsohn FA, Allen AM, Clevers J, Denton DA, Tarjan E, McKinley MJ. Localization of angiotensin II receptor binding in rabbit brain by in vitro autoradiography. J Comp Neurol 1988; 270:372-384.
42. Oldfield BJ, Allen AM, Hards DK, McKinley MJ, Schlawe I, Mendelsohn FA. Distribution of angiotensin II receptor binding in the spinal cord of the sheep. Brain Res 1994; 650:40-48.
43. Potts PD, Allen AM, Horiuchi J, Dampney RA. Does angiotensin II have a significant tonic action on cardiovascular neurons in the rostral and caudal VLM? Am J Physiol Regul Integr Comp Physiol 2000; 279:R1392-R1402.
44. 1 receptor-like immunoreactivity in catecholaminergic neurons of the medulla oblongata. Neuroscience 1997; 81:503-513.
45. Jenkins TA, Allen AM, Chai SY, Mendelsohn FA. Interactions of angiotensin II with central catecholamines. Clin Exp Hypertens 1995; 17:267-280.
46. Zhu DN, Moriguchi A, Mikami H, Higaki J, Ogihara T. Central amino acids mediate cardiovascular response to angiotensin II in the rat. Brain Res Bull 1998; 45:189-197.
47. 1) receptor in the rostral ventrolateral medulla in rats. J Appl Physiol 2002; 92:2153-2161.
48. Allen AM, Dosanjh JK, Erac M, Dassanayake S, Hannan RD, Thomas WG. Expression of constitutively active angiotensin receptors in the rostral ventrolateral medulla increases blood pressure. Hypertension 2006; 47:1054-1061.
49. Fontes MAP, Silva LCS, Campagnole-Santos MJ, Khosla MC, Guertzenstein PG, Santos RAS. Evidence that angiotensin (1-7) plays a role in the central control of blood pressure at the ventrolateral medulla acting through specific receptors. Brain Res 1994; 665: 175-180.
50. Ito S, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF. Ventrolateral medulla AT1 receptors support blood pressure in hypertensive rats. Hypertension 2002; 40:552-559.
51. 1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge. J Ren Ang Aldost Syst 2001; 2 (Suppl I):S120-S124.
52. Ito S, Hiratsuka M, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF. Ventrolateral medulla AT1 receptors support arterial pressure in Dahl salt-sensitive rats. Hypertension 2003; 41:744-750.
53. DiBona GF, Jones SY. Sodium intake influences hemodynamic and neural responses to angiotensin receptor blockade in rostral ventrolateral medulla. Hypertension 2001; 37:1114-1123.
54. 1 receptors in the rostral ventrolateral medulla increases sympathetic activity under conditions of hypoxia. Am J Physiol Regul Integr Comp Physiol 2006; 290:R733-R740.
55. Dampney RA, Tan PS, Sheriff MJ, Fontes MA, Horiuchi J. Cardiovascular effects of angiotensin II in the rostral ventrolateral medulla: the push-pull hypothesis. Curr Hypertens Rep 2007; 9:222-227.
56. Gaudet EA, Godwin SJ, Head GA. Role of central catecholaminergic pathways in the actions of endogenous ANG II on sympathetic reflexes. Am J Physiol Regul Integr Com Physiol 1998; 275:R1174-R1184.
57. Head GA, Williams NS. Hemodynamic effects of central angiotensin I, II and III in conscious rabbits. Am J Physiol Regul Integr Com Physiol 1992; 263:R845-R851.
58. Llewellyn-Smith IJ, Phend KD, Minson JB, Pilowsky PM, Chalmers JP. Glutamate-immunoreactive synapses on retrogradely-labelled sympathetic preganglionic neurons in rat thoracic spinal cord. Brain Res 1992; 581:67-80.
59. Tagawa T, Fontes MAP, Potts PD, Allen AM, Dampney RA. The physiological role of AT1 receptors in the ventrolateral medulla. Braz J Med Biol Res 2000; 33:643-652.
60. Fontes MAP, Martins Pinge MC, Naves V, Campagnole-Santos MJ, Lopes OU, Khosia MC, Santos RA. Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats. Brain Res 1997; 750:305-310.
61. Fontes MAP, Baltatu O, Caligiorne SM, Campagnole-Santos MJ, Ganten D, Bader M, Santos RA. Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR (mREN2)27 rats. Physiol Genomics 2000; 2:137-142.
62. Zanzinger J, Czachurski J, Seller H. Nitric oxide in the ventrolateral medulla regulates sympathetic responses to systemic hypoxia in pigs. Am J Physiol Regul Integr Comp Physiol 1998; 275:R33-R39.
63. Saveedra JM, Correa FM, Plunkett LM, Israel A, Kurihara M, Shigematsu K. Binding of angiotensin and arterial natriuretic peptide in brain of hypertensive rats. Nature 1986; 320:758-760.
64. Stamler JF, Raizada MK, Fellows RE, Phillips MI. Increased specific binding of angiotensin II in the organum vasculosum of the laminae terminalis area of the spontaneously hypertensive rat brain. Neurosci Lett 1980; 17:173-177.
65. Muratani H, Ferrario CM, Averill DB. Ventrolateral medulla in spontaneously hypertensive rats: role of angiotensin II. Am J Physiol Regul Integr Comp Physiol 1993; 264:R388-R395.
66. Sved AF, Ito S, Sved JC. Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla. Curr Hypertens Rep 2003; 5:262-268.
67. Ferguson AV, Latchford KJ. Local circuitry regulates the excitability of rat neurohypophysial neurones. Exp Physiol 2000; 85:153S-161S.
68. Matsuura T, Kumagai H, Onimaru H, Kawai A, Iigaya K, Onami T, et al. Electrophysiological properties of rostral ventrolateral medulla neurons in angiotensin II 1a receptor knockout mice. Hypertension 2005; 46:349-354.
69. Gao L, Wang W, Wang W, Li H, Sumners C, Zucker IH. Effects of Angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats. Hypertension 2008; 51:521-527.
70. Gao L, Wang W-Z, Wang W, Zucker IH. Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism of sympathetic overactivity in heart failure. Hypertension 2008; 52:708-714.
71. 2\+ currents: intracellular mechanisms. Am J Physiol 1996; 271:C154-C163.
72. Gelband CH, Warth JD, Mason HS, Zhu M, Moore JM, Kenyon JL, et al. Angiotensin II type 1 receptor-mediated inhibition of K channel subunit kv2.2 in brain stem and hypothalamic neurons. Circ Res 1999; 84:352-359.
73. Li YW, Polson JW, Dampney RA. Angiotensin II excites vasomotor neurons but not respiratory neurons in the rostral and caudal ventrolateral medulla. Brain Res 1992; 577:161-164.
74. Li YW, Guyenet PG. Neuronal excitation by angiotensin II in the rostral ventrolateral medulla of the rat in vitro. Am J Physiol 1995; 268:R272-R277.
75. \+ current in neurons by an angiotensin II type 2 receptor fragment. Am J Physiol 1995; 268:C278-C282.
76. Martens JR, Wang D, Sumners C, Posner P, Gelbaud Ch. Angiotensin II type 2 receptor-mediated regulation of rat neuronal K\+ channels. Circ Res 1996; 79:302-309. (Pubitemid 26255883)
77. Silva AO, Santos RA. Fontes MA Blockade of endogenous angiotensin (1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone. Hypertension 2005; 46:341-348.
78. Tagawa T, Horiuchi J, Potts PD, Dampney RA. Sympathoinhibition after angiotensin receptor blockade in the rostral ventrolateral medulla is independent of glutamate and gamma-aminobutyric acid receptors. J Auton Nerv Syst 1999; 77:21-30.
79. Zhang K, Mayhan WG, Patel KP. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. Am J Physiol 1997; 273:R864-R872.
80. Zhang K, Patel KP. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA. Am J Physiol Regul Integr Comp Physiol 1998; 275:R728-R734.
81. Li YF, Mayhan WG, Patel KP. NMDA-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. Am J Physiol Heart Circ Physiol 2001; 281:H2328-H2336.
82. Kishi T, Hirooka Y, Sakai K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 2001; 38:896-901.
83. BadoerE, Ng CW,De Matteo R. Tonic sympathoinhibition arising from the hypothalamic PVN in the conscious rabbit. Brain Res 2002; 947:17-24.
84. Zhu GQ, Patel KP, Zucker IH, Wang W. Microinjection of ANG II into paraventricular nucleus enhances cardiac sympathetic afferent reflex in rats. Am J Physiol Heart Circ Physiol 2002; 282:H2039-H2045.
85. Li DP, Pan HL. Angiotensin II attenuates synaptic GABA release and excites paraventricular-rostral ventrolateral medulla output neurons. J Pharmacol Exp Ther 2005; 313:1035-1045.
86. Li YF, Mayhan WG, Patel KP. Angiotensin-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. Am J Physiol Regul Comp Physiol 2006; 290:R1035-R1043.
87. 1 receptor antagonism. Am J Physiol Regul Integr Comp Physiol 2003; 285:R1231-R1239.
88. LaGrange LP, Toney GM, Bishop VS. Effect of intravenous angiotensin II infusion on responses to hypothalamic PVN injection of bicuculline. Hypertension 2003; 42:1124-1129.
89. Chen QH, Pan HL. Signaling mechanisms of angiotensin II-induced attenuation of GABAergic input to hypothalamic presympathetic neurons. J Neurophysiol 2007; 97:3279-3287.
90. Li YF, Jackson KL, Stern JE, Rabeler B, Patel KP. Interaction between glutamate and GABA systems in the integration of sympathetic outflow by the paraventricular nucleus of the hypothalamus. Am J Physiol Heart Circ Physiol 2006; 291:2847-2856.
91. Shonis CA, Peano CA, Dillon GH, Waldrop TG. Cardiovascular responses to blockade of GABA synthesis in the hypothalamus of the spontaneously hypertensive rat. Brain Res Bull 1993; 31:493-499.
92. Takenaka K, Sasaki S, Uchida A, Fujita H, Nakamura K, Ichida T, et al. GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats. Am J Hypertens 1996; 9:964-972.
93. Hambley JW, Johnston GAR, Shaw J. Alterations in a hypothalamicGABA system in the spontaneously hypertensive rat. Neurochem Int 1984; 6:813-821.
94. Li DP, Pan HL. Role of gamma-aminobutyric acid (GABA)A and (GABA)B receptors in paraventricular nucleus in control of sympathetic vasomotor tone in hypertension. J Pharmacol Exp Ther 2007; 320:615-626.
95. Ng CW, De Matteo R, Badoer E. Effect of muscimol and L-NAME in the PVN on the RSNA response to volume expansion in conscious rabbits. Am J Physiol Renal Physiol 2004; 287:F739-F746.
96. Zucker IH, Liu JL. Angiotensin II-nitric oxide interactions in the control of sympathetic outflow in heart failure. Heart Fail Rev 2000; 5:27-43.
97. Patel KP, Li YF, Hirooka Y. Role of nitric oxide in central sympathetic outflow. Exp Biol Med 2001; 226:814-824.
98. Zhang K, Li YF, Patel KP. Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure. Am J Physiol Heart Circ Physiol 2001; 281:H995-H1004.
99. Zhu GQ, Goa L, Patel KP, Zucker IH, Wang W. ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure. J Appl Physiol 2004; 97:1746-1754. (Pubitemid 39425992)
100. McKeogh DF, O'Donaughy TL, Brooks VL. NO and endogenous angiotensin II interact in the generation of renal sympathetic nerve activity in conscious rats. Am J Physiol Heart Circ Physiol 2004; 286:H1258-H1265.
101. del Carmen Garcia M, Celuch SM, Adler-Graschinsky E. Possible participation of spinal nitric oxide in the control of the blood pressure in anesthetized rats. Brain Res 1997; 764:67-74.
102. Arnolda LF, McKitrick DJ, Llewellyn-Smith IJ, Minson JB. Nitric oxide limits pressor responses to sympathetic activation in rat spinal cord. Hypertension 2000; 36:1089-1092.
103. 1 receptor signalling pathways in neurons. Clin Exp Pharmacol Physiol 2002; 29:483-490.
104. Chan SHH, Hsu KS, Huang CC, Wang LL, Ou CC, Chan JYH. NAPDH oxidase-derived superoxide anion mediates angiotensin II-induced pressure effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res 2005; 97:772-780.
105. Zimmerman MC, Sharma RV, Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 2005; 45:717-723.
106. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003; 139:191-202.
107. Zimmerman MC, Lazartigues E, Lang FA, Sinnayah P, Ahmed IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 2002; 91:1038-1045.
108. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, et al. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 2004; 95:532-539.
109. Sun C, Sellers KW, Sumners C, Raizada MK. NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ Res 2005; 96:659-666.
110. Borg J, London J. Coper/zinc superoxidase dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro. J Neurosci Res 2002; 70:180-189.
111. Esobales N, Crespo MJ. Oxidative-nitrosative stress in hypertension. Curr Vasc Pharmacol 2005; 3:231-246.
112. Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2005; 46:533-539.
113. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 2004; 95:937-944.
114. 1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 2005; 288:H2271-H2279.
115. Erdos B, Broxon CS, King MA, Scarpace PJ, Tümer N. Acute pressor effect of central angiotensin II is mediated by NAD(P)H-oxidase-dependent production of superoxide in the hypothalamic cardiovascular regulatory nuclei. J Hypertens 2006; 24:109-116.
116. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, Iadecola C. NADPH oxidase contributes to angiotensin II signalling in the nucleus tractus solitarius. J Neurosci 2004; 24:5516-5524.
117. Krukoff TL. Central actions of nitric oxide in regulation of autonomic functions. Brain Res Brain Res Rev 1999; 30:52-65.
118. Zanzinger J. Mechanisms of action of nitric oxide in the brain stem: role of oxidative stress. Auton Neurosci 2002; 98:24-27.
119. Hirooka Y, Polson JW, Dampney RA. Pressor and sympathoexcitatory effects on nitric oxide in the rostral ventrolateral medulla. J Hypertens 1996; 14:1317-1324.
120. Armstead WM. Vasopressin-induced protein kinase C-dependent superoxide generation contributes to ATP-sensitive potassium channel but not calcium-sensitive potassium channel function impairment after brain injury. Stroke 2001; 32:1408-1414.
121. Reja V, Goodchild AK, Phillips JK, Pilowsky PM. Upregulation of angiotensin AT1 receptor and intracellular kinase gene expression in hypertensive rats. Clin Exp Pharmacol Physiol 2006; 33:690-695.
122. Yue Y, Qin Q, Cohen MV, Downey JM, Critz SD. The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc Res 2002; 55:681-689.
123. \+ channel inhibition by reactive oxygen species. Am J Physiol Cell Physiol 2002; 282:C461-C471.
124. 1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 1999; 30:2391-2398.
125. Frigo DE, Tang Y, Beckman BS, Scandurro AB, Alam J, Burow ME, McLachlan JA. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway. Carcinogenesis 2004; 25:249-261.
126. Zucker IH, Gao L. The regulation of sympathetic nerve activity by angiotensin II involves reactive oxygen species and MAPK. Circ Res 2005; 97:737-739.
127. 1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol 2009; 296:H1425-H1433.
128. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072:129-157.
129. 1 receptors. J Hypertens 2007; 25:399-406.
130. Zini S, Fournié-Zaluski MC, Chauvel E, Roques BP, Corvol P, Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 1996; 93:11968-11973.
131. Wright JW, Harding JW. Important role for angiotensin III and IV in the brain renin-angiotensin system. Brain Res Rev 1997; 25:96-124.
132. Speth RC, Brown TE, Barnes RD, Wright JW. Brain angiotensinergic activity: the state of our current knowledge. Proc West Pharmacol Soc 2003; 46:11-15.
133. 4 and their functions. Regul Pept 1995; 59:269-295.
134. Reaux A, Fournie-Zaluski MC, David C, Zini S, Roques BP, Corvol P, Llorens-Cortes C. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci USA 1999; 96:13415-13420.
135. 1] angiontensin II, as a pressor agent in rats. Brain Res 1990; 514:5-10.
136. 1 receptor subtype in cardiovascular function. Peptides 1996; 17:1365-1371.
137. Kokje RJ, Wilson WL, Brown TE, Karamyan VT, Wright JW, Speth RC. Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis. Hypertension 2007; 49:1328-1335.
138. 1 angiotensin receptor subtype binding: Importance of peptidase inhibition for identification of angiotensin II as its endogenous ligand. J Pharmacol Exp Ther 2009; 331:170-177.
139. Lochard N, Thibault G, Silversides DW, Touyz RM, Reudelhuber TL. Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist. Circ Res 2004; 94:1451-1457.
140. Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 2006; 47:515-521.
141. Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 2007; 292:R373-R381.
142. Iusuf D, Henning RH, van Gilst WH, Roks AJ. Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives. Eur J Pharmacol 2008; 585:303-312.
143. Schiavone MT, Santos RA, Brosnihan KB, Khosla MC, Ferrario CM. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA 1988; 85:4095-4098.
144. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM. Identification of angiotensin-(1-7) in rat brain: evidence for differential processing of angiotensin peptides. J Biol Chem 1989; 264:16518-16521.
145. Santos RAS, Campagnole-Santos MJ, Andrade SP. Angiotensin-(1-7): an update. Regul Pept 2000; 9:45-62.
146. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417:822-828.
147. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin-1-9. Circ Res 2000; 87:1-9.
148. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275:33238-33243.
149. Vickers C, Hales P, Kaushik V. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277:14838-14843.
150. Santos RAS, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003; 100:8258-8263.
151. Bunnemann B, Fuxe K, Metzger R, Mullins J, Jackson TR, Hanley MR, Ganten D. Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization. Neurosci Lett 1990; 114:147-153.
152. Metzger R, Bader M, Ludwig T, Berberich C, Bunnemann B, Ganten D. Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett 1995; 357:27-32.
153. Becker LK, Etelvino GM, Walther T, Santos RAS, Campagnole-Santos MJ. Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am J Physiol Heart Circ Physiol 2007; 293:H1416-H1424.
154. Santos RA, Campagnole-Santos MJ. Central and peripheral actions of angiotensin-(1-7). Braz J Med Biol Res 1994; 27:1033-1047.
155. Chaves GZ, Caligiorne SM, Santos RA, Khosia MC, Campagnole-Santos MJ. Modulation of the baroreflex control of heart rate by angiotensin (1-7) at the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats. J Hypertens 2000; 18:1841-1848.
156. Yamazato M, Yamazato Y, Sun C, Diez-Freire C, Raizada MK. Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 2007; 49:926-931.
157. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of the circulation in heart failure. Circulation 1997; 96:1173-1179.
158. Sakata K, Shirotani M, Yoshida H, Kurata C. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension. J Am Coll Cardiol 1998; 32:438-443.
159. Grassi G, Turri C, Dell'Oro R, Stella ML, Bolla GB, Mancia G. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. J Hypertens 1998; 16:1789-1796.
160. Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol 2006; 290:H1706-H1712.
161. Mijajima E, Shigemasa T, Yamada Y, Tochikubo O, Ishii M. Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans. Clin Exp Pharmacol Physiol 1999; 26:797-802.
162. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Jensen G, Friberg P. Differentiated response of the sympathetic nervous system to angiotensin-converting-enzyme inhibition in hypertension. Hypertension 2000; 36:543-548.
163. Johansson M, Rundqvist B, Petersson M, Lambert G, Friberg P. Regional norepinephrine spillover in response to angiotensin-converting-enzyme inhibition in healthy volunteers. J Hypertens 2003; 21:1371-1375.
164. Rodriguez-Garcia JL, Villa E, Serrano M, Gallardo J, Garcia-Robles R. Comparison of the effects of four ACE inhibitors on sympathetic reactivity to cold pressor test in essential hypertensive patients. Eur J Int Med 1999; 10:106-111.
165. Israel A, Zavala LE, Cierco M, Gutierrez A, Garrido M. Effect of eprosartan on the sympathetic response to cold pressor test in healthy volunteers. Auton Neurosci 2006; 126:179-184.
166. Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 2004; 15:524-537.
167. Ligtenberg G, Blankestijn PJ, Oey PL, Klain IH, Dijkhorst-Oei LT, Boomsma F, et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340:1321-1328.
168. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol 2003; 14:425-430.
169. Blankestijn PJ, Ligtenberg G, Klein IHHT, Koomans HA. Sympathetic overactivity in renal failure controlled by ACE inhibition: clinical significance. Nephrol Dial Transplant 2000; 15:755-758.